1 天
Study Finds on MSNWhen Good Cells Turn Bad: Scientists Discover Why Psoriasis Won’t Go AwayDiscover how psoriasis affects immune function and the role of SSAT1 in this chronic skin condition. Learn more now.
Join Drs Steven Feldman and Jules Lipoff as they discuss teledermatology, the cost of prescriptions, and other barriers to care people with psoriasis face.
Adults taking the novel once-daily oral pill for plaque psoriasis have significantly higher rates of clear or almost clear ...
前言银屑病也叫牛皮癣。虽然世界范围内,中国人的患病率是最低之一。但是,中国的患病总数仍有230万(95%CI:0.9-610万),居世界第三(全世界前7名排序为:美国、印度、中国、德国、巴西、法国、英国)[1]。银屑病因为有各种并发症,且提示心脑血管 ...
12 天
MedPage Today on MSNInitiating Systemic Therapy for PsoriasisUntil about 20 years ago, systemic treatment options for moderate/severe psoriasis were limited and nonspecific. To get an ...
11 天
MedPage Today on MSNTopical Therapies for PsoriasisOptimizing use of topical agents begins with defining "mild or moderate." Clinical trials in psoriasis employ objective ...
Psoriasis is a chronic, recurrent and inflammatory skin disorder associated with immune system dysregulation. The abnormal ...
Mar. 3, 2025 — Psoriasis is one of the most common chronic inflammatory skin diseases, affecting around 250,000 people in Austria. While previous treatment approaches have mainly focused on ...
Steqeyma is indicated for the treatment of plaque psoriasis and psoriatic arthritis in adult and pediatric patients, as well ...
Three months after Bristol Myers Squibb revealed the success of two phase 3 trials of its oral targeted therapy Sotyktu in ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果